ZBIOZenas BioPharma, Inc.vs its industry peers
A metric-by-metric comparison of Zenas BioPharma, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZBIO본 종목 | $1.9B#7 | — | 7.6x#9 | 188.2x#9 | 100.0%#5 | -140.6%#9 | -3830.6%#10 | -152.9%#11 | -296.6%#6 | — | — | — |
| PRGO | $2.2B#1 | — | 0.9x#1 | 0.5x#1 | -2.8%#10 | -729.7%#12 | -26.4%#3 | -56.7%#8 | -20.9%#2 | 4#1 | -18.1%#4 | 7.3%#1 |
| ZYME | $2.2B#2 | — | 26.8x#11 | 20.3x#6 | 38.9%#6 | 33.9%#3 | -87.3%#6 | -100.9%#10 | — | — | — | — |
| SEPN | $2.0B#3 | — | 5.3x#6 | 44.3x#8 | 4174.5%#1 | 31.9%#4 | -148.6%#7 | -12.6%#4 | — | — | 117.6%#2 | — |
| TRVI | $2.0B#4 | — | 6.2x#7 | — | — | 10.7%#6 | — | -13.3%#5 | — | — | — | — |
| SRPT | $2.0B#5 | — | 1.3x#2 | 1.1x#2 | 4.3%#9 | -403.3%#11 | -37.5%#4 | -46.7%#7 | -73.0%#3 | — | — | — |
| BRVE | $1.9B#6 | — | — | — | — | — | — | — | — | — | — | — |
| PGEN | $1.9B#8 | — | 42.5x#12 | 191.3x#10 | 146.7%#4 | -98.6%#8 | -1141.1%#9 | -575.1%#12 | -91.2%#5 | — | 24.5%#3 | — |
| GENB | $1.8B#10 | — | 3.9x#4 | — | — | — | — | 0.0%#1 | — | — | — | — |
| SLS | $1.8B#11 | — | 12.9x#10 | — | -100.0%#11 | 13.0%#5 | — | -19.5%#6 | — | — | 390.0%#1 | — |
| STOK | $1.8B#9 | — | 5.1x#5 | 9.7x#5 | 404.5%#3 | 92.3%#1 | -11.2%#2 | -2.0%#2 | — | — | — | — |
| SUPN | $1.7B#12 | — | 1.6x#3 | 2.4x#3 | 8.6%#8 | -152.2%#10 | -8.7%#1 | -3.6%#3 | -4.8%#1 | — | — | — |
| NUVB | $1.7B#13 | — | 6.6x#8 | 26.5x#7 | 699.0%#2 | 64.0%#2 | -338.7%#8 | -80.6%#9 | -87.4%#4 | — | — | — |
| RARE | $1.7B#14 | — | — | 2.5x#4 | 20.2%#7 | -1.1%#7 | -79.5%#5 | — | — | — | -49.7%#5 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice